Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-24 @ 11:40 PM
NCT ID:
NCT04962451
Eligibility Criteria:
Inclusion Criteria:
1. Over 40 years old
2. Acute ischemic attack
3. Symptoms occurred within 24 hours after randomization
Exclusion Criteria:
1. Dual antiplatelet therapy with ASA and P2Y12 inhibitors is needed
2. Antiplatelet agents other than ASA
3. Anticoagulant therapy
4. Have any atrial fibrillation / flutter
5. Renal failure requiring dialysis
6. During pregnancy or lactation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT04962451
Study Brief:
Protocol Section:
NCT04962451